Evidence map›Paper›PMID 39116422›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Ponicidin Promotes Hepatocellular Carcinoma Mitochondrial Apoptosis by Stabilizing Keap1-PGAM5 Complex.

Bixin Zhao, Zuhui Liang, Lisheng Zhang, Lin Jiang, Yuanhang Xu, Ying Zhang, Rong Zhang, Caiyan Wang, Zhongqiu Liu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Ponicidin attenuates AβMolecular biology reports · 2025
    Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bixin ZhaoState Key Laboratory of Traditional Chinese Medicine Syndrome, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Zuhui LiangState Key Laboratory of Traditional Chinese Medicine Syndrome, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Lisheng ZhangResearch Center of Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Lin JiangState Key Laboratory of Traditional Chinese Medicine Syndrome, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Yuanhang XuState Key Laboratory of Traditional Chinese Medicine Syndrome, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Ying ZhangState Key Laboratory of Traditional Chinese Medicine Syndrome, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Rong ZhangState Key Laboratory of Traditional Chinese Medicine Syndrome, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Caiyan WangState Key Laboratory of Traditional Chinese Medicine Syndrome, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.ORCID 0000-0002-8605-2340
Zhongqiu LiuState Key Laboratory of Traditional Chinese Medicine Syndrome, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.

Funding

Guangdong Key Laboratory for translational Cancer research of Chinese Medicine 2023B1212060061Key-Area Research and Development Program of Guangdong Province 2020B1111100004National Natural Science Foundation of China 82274214National Natural Science Foundation of China U22A20368Research Foundation of Education Bureau of Guangdong Province 2022ZDZx02010Research Foundation of Education Bureau of Guangdong Province 2022ZDZX2010The Talent Support Project of Guangdong 2021JC050230
6 · The paper itself

Abstract

Ponicidin is a diterpenoid with demonstrated antitumor activity in clinical trials. However, the specific function and mechanism of action against hepatocellular carcinoma (HCC) remain unknown. In this study, it is found that ponicidin significantly inhibited the proliferation and migration of HCC cells. It is shown that ponicidin targets Keap1 and promotes the formation of the Keap1-PGAM5 complex, leading to the ubiquitination of PGAM5, using biotin-labeled ponicidin for target fishing and the HuProt

Indexed as

ApoptosisCarcinoma, HepatocellularKelch-Like ECH-Associated Protein 1Liver NeoplasmsMitochondriaAnimalsCell Line, TumorCell ProliferationDisease Models, AnimalDiterpenesHep G2 CellsHumansMiceMice, Inbred BALB CMice, NudeMitochondrial ProteinsDiterpenesKEAP1 protein, humanKelch-Like ECH-Associated Protein 1Mitochondrial ProteinsPGAM5 protein, humanPhosphoprotein PhosphatasesPlant ExtractsponicidinapoptosisHepatocellular carcinomaKeap1mitochondrial functionPGAM5ponicidin

Identifiers

PMID39116422
PMCPMC11481384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.